Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences
MJH Life Sciences

SUBSCRIBE: Print / eNewsletter

Gynecologic Cancers

Sorafenib Offers Survival Improvements in Ovarian Cancer

August 24, 2018
  • Dave Levitan

Sorafenib combined with topotecan and then continued as maintenance therapy offered a significant improvement in survival outcomes in women with platinum-resistant ovarian cancer.

  • READ >>
ovarian cancer, ovary, gynecology

Apatinib/Etoposide Promising in Platinum-Resistant Ovarian Cancer

August 22, 2018
  • Dave Levitan

Apatinib combined with etoposide offers promising efficacy in patients with platinum-resistant ovarian cancer.

  • READ >>

Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer Points

August 15, 2018
  • Leslie R. Boyd, MD
  • Franco M. Muggia, MD

The regimen consisting of carboplatin and paclitaxel represents the backbone of ovarian cancer treatment. Here, we reflect on our experience administering the carboplatin/paclitaxel regimen to scores of ovarian cancer patients over the past decade and a half.

  • READ >>

Tumor Vasculature Remains Stable Through Progression of Ovarian Cancer

July 25, 2018
  • Dave Levitan

The intratumoral vasculature of high-grade serous ovarian cancer does not appear to undergo significant changes during disease progression.

  • READ >>

Does Analgesic Use Improve Survival in Ovarian Cancer?

July 23, 2018
  • Dave Levitan

Recent use of aspirin or NSAIDs is associated with improved ovarian cancer–specific survival.

  • READ >>

MGH Program Supports Sexual Health of Women Receiving Pelvic RT for Gastrointestinal and Gynecologic Malignancies

July 18, 2018
  • Lorraine Drapek, DNP, FNP-BC, AOCNP

In an interview with Cancer Network, Lorraine Drapek describes a multidisciplinary program at MGH to support vaginal and sexual health post RT for GI and gynecologic malignancies.

  • READ >>

Using PARP Inhibitors in Advanced Ovarian Cancer

July 15, 2018
  • Roisin E. O’Cearbhaill, MD

The approval of PARP inhibitors has caused a paradigm shift in ovarian cancer management and a challenge for clinicians, who must decide how best to use these agents in individualized treatment.

  • READ >>

Can Anxiety and Early Life Adversity Affect Ovarian Cancer Outcomes?

June 21, 2018
  • Dave Levitan

In women with ovarian cancer, those with early life adversity and anxiety had more dysregulation of cortisol, suggesting they may be at risk for more negative outcomes.

  • READ >>

Bevacizumab Rechallenge Benefit in Recurrent Ovarian Cancer?

June 18, 2018
  • John Schieszer

New data suggest adding bevacizumab to chemotherapy may prolong PFS in patients with recurrent ovarian cancer.

  • READ >>

Noninferiority of Neoadjuvant Chemo Cannot Be Confirmed in Ovarian Cancer Trial

June 6, 2018
  • Dave Levitan

The noninferiority of neoadjuvant chemotherapy vs upfront surgery could not be confirmed with regard to overall survival in patients with ovarian, tubal, and peritoneal cancers.

  • READ >>

Pages

  • « first
  • ‹ previous
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Breast Cancer
  • Acute Myeloid Leukemia
  • HER2-Positive Breast Cancer
  • Videos Breast Cancer
  • Follicular Lymphoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

ONCOLOGY Vol 33 No 11
Nov 21, 2019 Vol 33 No 11
Subscribe
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".